These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
606 related items for PubMed ID: 12698396
1. Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery. Oliver WC, Nuttall GA, Ereth MH, Santrach PJ, Buda DA, Schaff HV. J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):165-70. PubMed ID: 12698396 [Abstract] [Full Text] [Related]
2. Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance. Ovrum E, Am Holen E, Tangen G, Ringdal MA. Ann Thorac Surg; 1996 Oct; 62(4):1128-33. PubMed ID: 8823101 [Abstract] [Full Text] [Related]
4. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization. Gunaydin S, Farsak B, McCusker K, Vijay V, Sari T, Onur MA, Gurpinar A, Zorlutuna Y. J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380 [Abstract] [Full Text] [Related]
5. Clinical use of heparin-coated cardiopulmonary bypass in coronary artery bypass grafting. Mirow N, Minami K, Kleikamp G, Tenderich G, Puhlmann T, Körfer R. Thorac Cardiovasc Surg; 2001 Jun; 49(3):131-6. PubMed ID: 11432470 [Abstract] [Full Text] [Related]
10. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin. Dietrich W, Spannagl M, Boehm J, Hauner K, Braun S, Schuster T, Busley R. Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201 [Abstract] [Full Text] [Related]
11. Evaluation of heparin-coated circuits with full heparin dose strategy. Sinci V, Kalaycioglu S, Gunaydin S, Imren Y, Gokgoz L, Soncul H, Ersoz A. Ann Thorac Cardiovasc Surg; 1999 Jun; 5(3):156-63. PubMed ID: 10413761 [Abstract] [Full Text] [Related]
12. A prospective, randomized study of the effects of prostacyclin on platelets and blood loss during coronary bypass operations. Fish KJ, Sarnquist FH, van Steennis C, Mitchell RS, Hilberman M, Jamieson SW, Linet OI, Miller DC. J Thorac Cardiovasc Surg; 1986 Mar; 91(3):436-42. PubMed ID: 3512919 [Abstract] [Full Text] [Related]
13. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass. Tamim M, Demircin M, Guvener M, Peker O, Yilmaz M. Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115 [Abstract] [Full Text] [Related]
14. Coronary artery bypass surgery with heparin-coated perfusion circuits and low-dose heparinization. Mullen JC, Bentley MJ, Gelfand ET, Koshal A, Modry DL, Guenther CR, Etches WS, Stang LJ, Lopushinsky SR. Can J Surg; 2002 Jun; 45(3):166-72. PubMed ID: 12067167 [Abstract] [Full Text] [Related]
15. Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations. Ovrum E, Tangen G, Oystese R, Ringdal MA, Istad R. J Thorac Cardiovasc Surg; 2001 Feb; 121(2):324-30. PubMed ID: 11174738 [Abstract] [Full Text] [Related]